Thailand Customs Seized 1 Million E-cigarettes in 9 Months

Regulations by 2FIRSTS.ai
Jul.16.2024
Thailand Customs Seized 1 Million E-cigarettes in 9 Months
Thailand Customs seize 1 million e-cigarettes in 9 months, worth $35.38 million, as more locals turn to vaping.

According to a report in the Daily News on July 16th, Thai customs has seized 1 million e-cigarettes in the past 9 months.

 

The spokesperson for the Customs Department of Thailand, Panthong Loikunnan, revealed that during the period from October 1, 2023 to June 30, 2024, the Customs General Administration has identified a total of 3,611 cases of illegal import and export of goods, with a total value of 1.282 billion Thai Baht (35.38 million US dollars). Among these cases, important items include e-cigarettes, e-cigarette devices, e-cigarette liquids, Arabian shishas, and electronic hookahs, with a total of 280 cases involving 957,033 items, valued at 82.7 million Thai Baht (2.28 million US dollars). Additionally, 1,496 cases involving cigarettes were also identified, with a total of 22.8 million cigarettes valued at 1.35 billion Thai Baht (3.73 million US dollars).

 

Interestingly, this year the department seized nearly one million e-cigarettes, as more and more Thai people are turning to e-cigarettes instead of traditional cigarettes. Specifically, young people are increasingly shifting towards e-cigarettes, even though they are illegal products, there is still a large amount of smuggling taking place.

 

The General Administration of Customs has responded to policies by further strengthening the work of customs inspection stations nationwide, increasing patrols, setting up inspection points and interception points, especially at borders, natural channels, and various transit points, including major and minor routes, to prevent and deter illegal activities, particularly drug smuggling, illegal goods, and various illegal products transport, such as drugs, e-cigarettes and devices, cannabis smoke, non-compliant products (TISI), goods infringing on intellectual property rights, agricultural products (including rubber and pork and their edible parts), and fuel, etc. In addition, they are collaborating with relevant departments, sharing intelligence information, and taking in-depth actions to crackdown on the import and export of illegal goods in accordance with the policies of the Prime Minister.

 

According to Pan Tong, in the 2024 fiscal year, the total revenue of the Thai Customs Department was 469.62 billion baht (13 billion US dollars), with customs revenue at 88.32 billion baht (2.4 billion US dollars), exceeding expected revenue by 2.802 billion baht (77.33 million US dollars), an increase of 3.3%. In addition, revenue collected on behalf of other departments was 381.231 billion baht (10.5 billion US dollars), with 293.928 billion baht (8.1 billion US dollars) collected on behalf of the Revenue Department, 49.676 billion baht (1.4 billion US dollars) collected on behalf of the Customs Department, and 37.626 billion baht (1 billion US dollars) collected on behalf of the Ministry of Interior.

 

The General Administration of Customs has stated that it will continue to take measures to improve tax collection and management efficiency, as well as close tax loopholes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
China’s State Council has appointed Zhang Xiaotang as deputy director of the State Tobacco Monopoly Administration, with the regulator’s official website now listing him as a Party leadership group member and deputy director. Zhang previously led Hebei China Tobacco and earlier headed the STMA’s finance and audit department. His appointment follows the elevation earlier this year of former tax official Yao Laiying to head the STMA, adding another senior official with a strong fiscal or financial-management background to China Tobacco’s top leadership in 2026.
News
Sep.20
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
China's Ministry of Finance and State Taxation Administration announced on October 12, 2026, that value-added tax (VAT) export rebates for vape devices, nicotine and its salts, and certain non-combustible inhalation products will be eliminated from April 1, 2027. The measure adds four tobacco- and nicotine-related customs codes, including 8543400010, which covers vape devices and qualifying empty pods. China previously eliminated rebates for nicotine-containing vaping products and devices under code 8543400090 in April 2026. According to industry classification information held by 2Firsts, the latter currently corresponds to heated tobacco devices. Export excise tax refund and exemption arrangements will remain unchanged.
Special Report
Oct.12
Special Report | Vape bans and tougher rules: the South Caucasus takes different paths
Special Report | Vape bans and tougher rules: the South Caucasus takes different paths
Azerbaijan's sweeping e-cigarette ban has raised concerns over enforcement errors and the emergence of illicit sales, while neighboring Armenia is tightening technical rules and preparing higher excise taxes. Georgia, meanwhile, has resisted calls for broader vape restrictions and introduced preferential taxes for some domestically produced cigarettes. The divergent approaches across the South Caucasus highlight a regional policy dilemma: how to curb nicotine use and protect public health without encouraging black markets or creating unintended economic consequences for businesses and consumers.
Nov.03
Special Report | From Oversupply to Supply Gaps: Global Tobacco Leaf Markets Diverge Ahead of 2027
Special Report | From Oversupply to Supply Gaps: Global Tobacco Leaf Markets Diverge Ahead of 2027
Global tobacco leaf markets diverged sharply in 2026, with India cutting authorised FCV production amid oversupply while Malawi faced a supply shortfall. U.S. demand improved in some leaf categories, but growers in Brazil, Colombia, Tanzania and Zimbabwe faced pressure from prices, buyer access, costs and weather. With nicotine consumption patterns also shifting, 2027 will test whether supply, demand and grower profitability can move back toward balance.
Oct.26
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives